The standardized mortality rate from bladder malignant neoplasms in Germany is forecasted to decline from 7.3 in 2024 to 6.5 by 2028 per hundred thousand men. The year-on-year percentage variation shows a consistent decline of approximately 2.7% annually, demonstrating a positive trend toward reducing mortality. With the forecasted average annual decrease (CAGR) over this five-year period, bladder cancer mortality is on a progressive downward trajectory compared to 2023 figures.
Future trends to watch for include advancements in medical technology and treatment methods, early diagnosis initiatives, and public health policies aimed at better management and prevention of bladder cancer.
